{
    "clinical_study": {
        "@rank": "92582", 
        "arm_group": [
            {
                "arm_group_label": "Young males", 
                "description": "Healthy, Lean, Caucasian, Young males"
            }, 
            {
                "arm_group_label": "Old males", 
                "description": "Healthy, Lean, Caucasian, Older males"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study the investigators aim to investigate whether the sympathetic stimulation of\n      BAT, as assessed with a 123I-metaiodobenzylguanidine single-photon emission computed\n      tomography computed tomography scan, differs between young and elderly subjects, as an\n      explanation for the diminished metabolic brown adipose tissue activity in the elderly.\n\n      The investigators hypothesis is that sympathetic nervous system activity in the elderly is\n      diminished as compared to their younger counterparts as an explanation for the diminished\n      metabolic brown adipose tissue activity in the elderly."
        }, 
        "brief_title": "Brown Adipose Tissue Activity and Age", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Obesity", 
            "Ageing"
        ], 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "detailed_description": {
            "textblock": "The sympathetic nervous system is the primary activator of Brown Adipose Tissue.\n\n      Elderly are known to have less metabolically active brown adipose tissue as compared to\n      their younger counterparts.\n\n      The reason for this diminished metabolic brown adipose tissue activity is unknown.\n\n      However, a lower sympathetic nervous system activation to brown adipose tissue in the\n      elderly might explain a diminished metabolic brown adipose tissue.\n\n      Therefore, in this study, both the sympathetic nervous system activation to brown adipose\n      tissue and the metabolic activity will be measured in young and older subjects.\n\n      sympathetic nervous system activity will be measured using 123I-metaiodobenzylguanidine\n      single-photon emission computed tomography computed tomography scans, metabolic activity\n      will be measured using 18F- fluorodeoxyglucose positron emission tomography CT scans."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male\n\n          -  Caucasian origin\n\n          -  Subjects should be able and willing to give informed consent\n\n          -  18-65 years old\n\n          -  BMI range of 19-27 kg/m2\n\n        Exclusion Criteria:\n\n          -  Renal failure (creatinine>135mmol/l)\n\n          -  Daily use of prescription medication\n\n          -  Prior participation in a research protocol involving radiation exposure in the last 2\n             years"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Healthy Caucasian Males"
            }
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02130154", 
            "org_study_id": "NL 42422.018.12 METC 2012.319"
        }, 
        "intervention": {
            "arm_group_label": [
                "Young males", 
                "Old males"
            ], 
            "intervention_name": "18-FDG PET CT scan and 123I-MIBG SPECT scan", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Brown adipose Tissue", 
            "Ageing", 
            "Sympathetic Nervous Stimulation", 
            "Obesity"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Amsterdam", 
                    "country": "Netherlands", 
                    "zip": "1105AZ"
                }, 
                "name": "Academic Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "2", 
        "official_title": "Brown Adipose Tissue Activity Young and Older Individuals", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Difference in sympathetic stimulation to BAT between young and older individuals", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for a mean duration of 2 weeks (the maximal time period between the two scans) The outcome measurements will be assessed when the last subject has been scanned approximately one year after starting the trial."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02130154"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "investigator_full_name": "F Holleman", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The difference in correlation between sympathetic stimulation of BAT as assessed with a MIBG SPECT-CT scan, and BAT activity itself as assessed with 18F-FDG-PET-CT, between young and elderly subjects", 
            "measure": "Difference in correlation between sympathetic stimulation of BAT as assessed with 123I-MIBG SPECT scans and metabolic BAT activity as assessed with 18F-Fluorodeoxyglucose(FDG)- positron emission tomography(PET)-CT scan in young and older individuals", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for a mean duration of 2 weeks (the maximal time period between the two scans) The outcome measurements will be assessed when the last subject has been scanned approximately one year after starting the trial."
        }, 
        "source": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}